Oncotar 500mg Injection
By Oncotar
Rx
5ml Injection in a Vial

Composition
Cytarabine(500mg)

Manufacturer - United Biotech Pvt Ltd
FC/B-1 (Extn.), Mohan Co-operative Industrial Estate Mathura Road, New Delhi - 110 044

Expires on or after
November, 2026

liver
Limited information exists regarding the use of Oncotar 500mg Injection in individuals with liver conditions. Hence, it is strongly advised to seek guidance from your healthcare provider. Due to the lack of extensive data, it is recommended to exercise caution when utilizing Oncotar 500mg Injection in patients with liver issues.

kidney
Oncotar 500mg Injection is safe for patients with kidney disease without needing a dose adjustment. It is still important to inform your doctor about any existing kidney conditions.

alcohol
Consult your doctor when consuming alcohol with Oncotar 500mg Injection.

driving
Oncotar 500mg Injection may cause side effects impacting driving ability.

pregnancy
Oncotar 500mg Injection is considered unsafe during pregnancy due to potential risks to the developing baby. However, in life-threatening situations, a doctor may prescribe it if benefits outweigh risks. Consult your doctor.

breastfeeding
Oncotar 500mg Injection is not recommended for use while breastfeeding as it may cause toxicity to the baby. It is better to consult your doctor before using Oncotar 500mg Injection.
| Habit Forming | No |
| Chemical Class | Pyrimidine Nucleoside Analogue |
| Therapeutic Class | ANTI NEOPLASTICS |
| Action Class | Antimetabolites |
₹455.4
₹495
8% OFF
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024
